Publication | Open Access

The synthesis and bioactivity of pyrrolo[2,3-d]pyrimidine derivatives as tyrosine kinase inhibitors for NSCLC cells with EGFR mutations

Medicinal ChemistryBiochemistryNatural SciencesMedicineNsclc CellsTyrosine Kinase InhibitorsEgfr MutationsAnti-cancer AgentDrug DevelopmentChemical BiologyPharmacologyDrug Discovery